Potential Liability, Lack Of Incentives Complicate Cross-Labeling Ventures

Industry trade groups should explore incentives such as tax breaks to get drug companies to partner with device firms commercializing novel products, participants suggested at a Jan. 11-12 combo product summit

More from Archive

More from Medtech Insight